Literature DB >> 1955081

Multihormonal regulation of the human prolactin gene expression from 5000 bp of its upstream sequence.

M Berwaer1, P Monget, B Peers, M Mathy-Hartert, E Bellefroid, J R Davis, A Belayew, J A Martial.   

Abstract

We have cloned DNA sequences extending up to 6000 bp upstream from the first exon of the human prolactin (hPRL) gene. 5000 bp of these upstream sequences were fused to a CAT reporter gene and shown to provide tissue-specific transient expression in rat pituitary GH3 cells. Multihormonal response was found in this transient expression assay, leading to significant 2- to 5-fold induction by addition of 8-chlorophenylthio-cyclic AMP, thyrotropin-releasing hormone, epidermal growth factor, basic fibroblast growth factor, phorbol myristate acetate, a calcium channel agonist (Bay K-8644) and triiodothyronine. A 3-fold inhibition was observed in the presence of the glucocorticoid agonist dexamethasone. The sequence of the hPRL promoter was determined up to coordinate -3470. Computer similarity search between the rat and human sequences showed two highly conserved regions corresponding to the proximal and distal tissue specific enhancers described in both PRL promoters.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955081     DOI: 10.1016/0303-7207(91)90142-f

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  11 in total

Review 1.  Estrogen receptor interaction with estrogen response elements.

Authors:  C M Klinge
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

Review 2.  Prolactin as an autocrine/paracrine factor in breast tissue.

Authors:  C V Clevenger; T L Plank
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

Review 3.  Prolactin and its significance in the placenta.

Authors:  Meenakshi Rana; Sidhant Jain; Pooja Choubey
Journal:  Hormones (Athens)       Date:  2022-05-11       Impact factor: 2.885

4.  Luman/CREB3 recruitment factor regulates glucocorticoid receptor activity and is essential for prolactin-mediated maternal instinct.

Authors:  Amanda C Martyn; Elena Choleris; Daniel J Gillis; John N Armstrong; Talya R Amor; Adam R R McCluggage; Patricia V Turner; Genqing Liang; Kimberly Cai; Ray Lu
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272

5.  Molecular interaction of BMP-4, TGF-beta, and estrogens in lactotrophs: impact on the PRL promoter.

Authors:  Damiana Giacomini; Marcelo Páez-Pereda; Johanna Stalla; Günter K Stalla; Eduardo Arzt
Journal:  Mol Endocrinol       Date:  2009-04-02

6.  Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription.

Authors:  I Shimon; A Hüttner; J Said; O M Spirina; S Melmed
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

Review 7.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

8.  Tumor necrosis factor-alpha activates the human prolactin gene promoter via nuclear factor-kappaB signaling.

Authors:  Sönke Friedrichsen; Claire V Harper; Sabrina Semprini; Michael Wilding; Antony D Adamson; Dave G Spiller; Glyn Nelson; John J Mullins; Michael R H White; Julian R E Davis
Journal:  Endocrinology       Date:  2005-10-27       Impact factor: 4.736

Review 9.  The prolactin gene: a paradigm of tissue-specific gene regulation with complex temporal transcription dynamics.

Authors:  K Featherstone; M R H White; J R E Davis
Journal:  J Neuroendocrinol       Date:  2012-07       Impact factor: 3.627

10.  Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling.

Authors:  A D Adamson; S Friedrichsen; S Semprini; C V Harper; J J Mullins; M R H White; J R E Davis
Journal:  Endocrinology       Date:  2007-11-15       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.